Can I contact factories directly on CNFX?

CNFX is an open directory. Each factory profile provides direct contact information.

Cellulose Polymer Chains Component – Chemical Manufacturing

Component Specifications

Definition

Cellulose polymer chains are linear polysaccharides composed of β(1→4) linked D-glucose units, specifically processed to pharmaceutical-grade microcrystalline cellulose standards. These chains form the structural backbone of MCC, providing compressibility, binding properties, and controlled disintegration in solid dosage forms through hydrogen bonding and mechanical interlocking.

Working Principle

The cellulose polymer chains function through intermolecular hydrogen bonding between hydroxyl groups on adjacent glucose units, creating a three-dimensional network that provides mechanical strength. During tablet compression, these chains deform plastically and form new hydrogen bonds, resulting in cohesive tablets with controlled porosity for optimal drug release.

Materials

Pharmaceutical-grade cellulose derived from α-cellulose wood pulp, purified to remove lignin, hemicellulose, and other impurities. Degree of polymerization: 200-300 glucose units. Crystallinity: 60-80%. Moisture content: ≤5% w/w. Ash content: ≤0.1%.

Technical Parameters

Bulk Density 0.30-0.45 g/cm³
Heavy Metals ≤10 ppm
Hausner Ratio 1.18-1.33
Loss on Drying ≤5.0%
Tapped Density 0.45-0.60 g/cm³
pH (10% suspension) 5.0-7.0
Compressibility Index 15-25%
Particle Size Distribution 90% between 20-100 μm

Standards

ISO 8871, USP-NF, EP, JP

Industry Taxonomies & Aliases

Commonly used trade names and technical identifiers for Cellulose Polymer Chains.

Parent Products

This component is used in the following industrial products

Pharmaceutical-Grade Microcrystalline Cellulose

Purified, partially depolymerized cellulose excipient for pharmaceutical formulations

View Product Details

Engineering Analysis

Risks & Mitigation

Microbial contamination
Batch-to-batch variability
Moisture sensitivity affecting compressibility
Potential interaction with active pharmaceutical ingredients

FMEA Triads

Trigger: Inadequate purification process
Failure: Presence of lignin or hemicellulose impurities
Mitigation: Implement multi-stage purification with validated removal efficiency testing

Trigger: Moisture absorption during storage
Failure: Reduced compressibility and tablet hardness
Mitigation: Use moisture-barrier packaging with desiccants and controlled storage conditions

Trigger: Particle size distribution outside specification
Failure: Poor flow properties and content uniformity
Mitigation: Implement real-time particle size monitoring and automated classification systems

Industrial Ecosystem

Compatible With

Interchangeable Parts

Compliance & Inspection

Tolerance

±5% for particle size distribution, ±2% for moisture content, ±3% for bulk density

Test Method

USP <1061> for powder properties, USP <621> for chromatography, ISO 21527 for microbial limits, laser diffraction for particle size analysis

Procurement Evaluation Criteria

Not customer reviews or live demand data. These dimensions support RFQ preparation and supplier evaluation.

Technical documentation

4/5

Manufacturing capability

4/5

Inspection readiness

5/5

Supplier transparency

3/5

These scores are example evaluation dimensions, not real customer ratings, country-specific buyer feedback, or live inquiry activity.

Related Components

Seeding Port

A precision port for introducing seed crystals into batch crystallization systems to initiate controlled crystal growth.

Sight Glass

A transparent window for visual inspection of fluid flow and crystallization processes in industrial systems.

Control Software

Specialized software for real-time monitoring and control of continuous flow pharmaceutical reactors, ensuring precise process parameters and regulatory compliance.

Conveyor Interface

Precision interface component connecting vial transport systems in pharmaceutical inspection machines

Frequently Asked Questions

What is the primary function of cellulose polymer chains in pharmaceutical tablets?

Cellulose polymer chains serve as a binder and disintegrant in tablets, providing mechanical strength through hydrogen bonding while allowing controlled drug release through their porous structure.

How do cellulose polymer chains differ from regular cellulose?

Pharmaceutical-grade cellulose polymer chains are highly purified, with controlled degree of polymerization and crystallinity, ensuring consistent compressibility, flow properties, and regulatory compliance for drug formulations.

What quality standards apply to pharmaceutical cellulose polymer chains?

They must comply with pharmacopeial standards including USP-NF, European Pharmacopoeia, and ISO 8871, with specific requirements for purity, particle size, moisture content, and heavy metal limits.

Can I contact factories directly?

Yes, each factory profile provides direct contact information.

Data Basis

CNFX manufacturer profiles, technical classification, publicly available product information, and ongoing plausibility checks.

Preliminary Technical Classification

This page supports structured research, RFQ preparation, and supplier evaluation. It does not replace buyer-led supplier qualification, standards review, or technical approval.

Cellulose Polymer Chains